These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Red blood cell alloimmunization among sickle cell Kuwaiti Arab patients who received red blood cell transfusion. Ameen R, Al Shemmari S, Al-Bashir A. Transfusion; 2009 Aug; 49(8):1649-54. PubMed ID: 19453992 [Abstract] [Full Text] [Related]
7. Red cell alloantibodies in patients with haemoglobinopathies. Hmida S, Mojaat N, Maamar M, Bejaoui M, Mediouni M, Boukef K. Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131 [Abstract] [Full Text] [Related]
8. Red blood cell alloimmunization: lessons from sickle cell disease. Treml A, King KE. Transfusion; 2013 Apr; 53(4):692-5. PubMed ID: 23565994 [No Abstract] [Full Text] [Related]
10. Red blood cell alloimmunization in sickle cell disease: prevalence in 2010. Miller ST, Kim HY, Weiner DL, Wager CG, Gallagher D, Styles LA, Dampier CD, Roseff SD, Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN). Transfusion; 2013 Apr; 53(4):704-9. PubMed ID: 22804353 [Abstract] [Full Text] [Related]
11. The prevention and management of alloimmunization in sickle cell disease: the benefit of extended phenotypic matching of red blood cells. Vichinsky EP. Immunohematology; 2012 Apr; 28(1):20-3. PubMed ID: 22646146 [No Abstract] [Full Text] [Related]
12. A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. Harm SK, Yazer MH, Monis GF, Triulzi DJ, Aubuchon JP, Delaney M. Am J Clin Pathol; 2014 Feb; 141(2):256-61. PubMed ID: 24436274 [Abstract] [Full Text] [Related]
13. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V. Transfusion; 2002 Jan; 42(1):37-43. PubMed ID: 11896310 [Abstract] [Full Text] [Related]
14. Study of the antigenic characteristics of red blood cells units and their sickle cell disease recipients and the G6PD activity of transfused red blood cells units. Le Gallo M, Moutereau S, Gentil M, Pirenne F. Transfus Clin Biol; 2024 Aug; 31(3):130-134. PubMed ID: 38462030 [Abstract] [Full Text] [Related]
15. [Red blood cell immunization in haemoglobinopathie: about 84 cases]. Ben Amor I, Louati N, Khemekhem H, Dhieb A, Rekik H, Mdhaffar M, Gargouri J. Transfus Clin Biol; 2012 Dec; 19(6):345-52. PubMed ID: 23103424 [Abstract] [Full Text] [Related]
16. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Natukunda B, Schonewille H, Ndugwa C, Brand A. Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949 [Abstract] [Full Text] [Related]
19. Impact of Red Blood Cell Antigen Matching on Alloimmunization and Transfusion Complications in Patients with Sickle Cell Disease: A Systematic Review. Fasano RM, Meyer EK, Branscomb J, White MS, Gibson RW, Eckman JR. Transfus Med Rev; 2019 Jan; 33(1):12-23. PubMed ID: 30122266 [Abstract] [Full Text] [Related]
20. [Study of 206 transfused sickle cell disease patients: immunization, transfusion safety and red blood cell supply]. Meunier N, Rodet M, Bonin P, Chadebech P, Chami B, Lee K, Habibi A, Bachir D, Galactéros F, Bierling P, Noizat-Pirenne F. Transfus Clin Biol; 2008 Dec; 15(6):377-82. PubMed ID: 19026581 [Abstract] [Full Text] [Related] Page: [Next] [New Search]